Packaging for AbbVie’s drug, Humira (adalimumab). The Pharmaceutical Accountability Foundation in … More the Netherlands alleges in court that AbbVie made “excessive profits” during the period from 2014 to 2018, prior to its going off patent in Europe. AbbVie denies the allegations. (AP…
